SECOND AMENDMENT AGREEMENTAmendment Agreement • March 16th, 2022 • BioLineRx Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 16th, 2022 Company Industry JurisdictionThis Amendment Agreement (“Amendment Agreement”), dated as of October 16, 2018 (the “Execution Date”), is between the University of Massachusetts (“University”), a not-for-profit, public institution of higher education of the Commonwealth of Massachusetts, established by Chapter 75 of the Massachusetts General Laws, as represented by its Medical School (Worcester campus), and Agalimmune Ltd (“Company”), a private limited company incorporated in England & Wales (company registration number 08504603) with registered address at 1st Floor Thavies Inn House, 3-4 Holborn Road, London, EC1N 2HA, United Kingdom.
SECOND AMENDMENT AGREEMENTAmendment Agreement • March 28th, 2019 • BioLineRx Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 28th, 2019 Company Industry JurisdictionThis Amendment Agreement (“Amendment Agreement”), dated as of October 16, 2018 (the “Execution Date”), is between the University of Massachusetts (“University”), a not-for-profit, public institution of higher education of the Commonwealth of Massachusetts, established by Chapter 75 of the Massachusetts General Laws, as represented by its Medical School (Worcester campus), and Agalimmune Ltd (“Company”), a private limited company incorporated in England & Wales (company registration number 08504603) with registered address at 1st Floor Thavies Inn House, 3-4 Holborn Road, London, EC1N 2HA, United Kingdom.